UniProt Q92831
Histone acetyltransferase KAT2B (Q92831)
Histone acetyltransferase KAT2B (UniProt Q92831), EC 2.3.1.48, 2.3.1.57: 50 experimental structures and 1 predicted model on GenesisL1, 16 ligands bound, 40 pockets. Binding sites, druggability and experiment against prediction…
- UniProt
- Q92831
- Protein
- Histone acetyltransferase KAT2B
- EC
- 2.3.1.48, 2.3.1.57
- Experimental structures
- 50
- Predicted models
- 1
- Ligands
- 16
- Pockets
- 40 · 11 records with a druggable one
Structures
51 records of Q92831 in the MolNFT archive: 50 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1CM0 | Crystal structure of the PCAF/COENZYME-a complex | x-ray diffraction | B, A | — | — |
| 1CM0 | Crystal structure of the PCAF/COENZYME-a complex | x-ray diffraction | B, A | — | — |
| 1JM4 | NMR Structure of P/CAF Bromodomain in Complex with HIV-1 Tat Peptide | solution nmr | B | — | — |
| 1JM4 | NMR structure of P/CAF bromodomain in complex with HIV-1 tat peptide | solution nmr | B | — | — |
| 1N72 | Structure and Ligand of a Histone Acetyltransferase Bromodomain | solution nmr | A | — | — |
| 1N72 | Structure and ligand of a histone acetyltransferase bromodomain | solution nmr | A | — | — |
| 1WUG | complex structure of PCAF bromodomain with small chemical ligand NP1 | solution nmr | A | — | — |
| 1WUG | Complex structure of pcaf bromodomain with small chemical ligand NP1 | solution nmr | A | — | — |
| 1WUM | Complex structure of PCAF bromodomain with small chemical ligand NP2 | solution nmr | A | — | — |
| 1WUM | Complex structure of pcaf bromodomain with small chemical ligand NP2 | solution nmr | A | — | — |
| 1ZS5 | Structure-based evaluation of selective and non-selective small molecules that block HIV-1 TAT and… | solution nmr | A | — | — |
| 1ZS5 | Structure-based evaluation of selective and non-selective small molecules that block HIV-1 tat and… | solution nmr | A | — | — |
| 2RNW | The Structural Basis for Site-Specific Lysine-Acetylated Histone Recognition by the Bromodomains of… | solution nmr | A | — | — |
| 2RNW | The structural basis for site-specific lysine-acetylated histone recognition by the bromodomains of… | solution nmr | A | — | — |
| 2RNX | The Structural Basis for Site-Specific Lysine-Acetylated Histone Recognition by the Bromodomains of… | solution nmr | A | — | — |
| 2RNX | The structural basis for site-specific lysine-acetylated histone recognition by the bromodomains of… | solution nmr | A | — | — |
| 3GG3 | Crystal Structure of the Bromodomain of Human PCAF | x-ray diffraction | A, B | — | — |
| 3GG3 | Crystal structure of the bromodomain of human pcaf | x-ray diffraction | A, B | — | — |
| 4NSQ | Crystal structure of PCAF | x-ray diffraction | A, B, C, D | — | — |
| 4NSQ | Crystal structure of pcaf | x-ray diffraction | A, B, C, D | — | — |
| 5FDZ | Crystal structure of human PCAF bromodomain in complex with compound BDOMB00091a (compound 14) | x-ray diffraction | A, B | 5X0 | 3 (best 0.62) |
| 5FDZ | Crystal structure of human pcaf bromodomain in complex with compound BDOMB00091A (compound 14) | x-ray diffraction | A, B | — | — |
| 5FE0 | Crystal structure of human PCAF bromodomain in complex with acetyllysine | x-ray diffraction | A, B | ALY | 3 (best 0.65) |
| 5FE0 | Crystal structure of human pcaf bromodomain in complex with acetyllysine | x-ray diffraction | A, B | — | — |
| 5FE1 | Crystal structure of human PCAF bromodomain in complex with fragment BR004 (fragment 1) | x-ray diffraction | A, B | 12Q | 3 (best 0.65) |
| 5FE1 | Crystal structure of human pcaf bromodomain in complex with fragment BR004 (fragment 1) | x-ray diffraction | A, B | — | — |
| 5FE2 | Crystal structure of human PCAF bromodomain in complex with fragment BR013 (fragment 3) | x-ray diffraction | A, B | 5WV | — |
| 5FE2 | Crystal structure of human pcaf bromodomain in complex with fragment BR013 (fragment 3) | x-ray diffraction | A, B | — | — |
| 5FE3 | Crystal structure of human PCAF bromodomain in complex with fragment MB360 (fragment 4) | x-ray diffraction | A, B | 5WX | — |
| 5FE3 | Crystal structure of human pcaf bromodomain in complex with fragment MB360 (fragment 4) | x-ray diffraction | A, B | — | — |
| 5FE4 | Crystal structure of human PCAF bromodomain in complex with fragment MB364 (fragment 5) | x-ray diffraction | A, B | 5WY | 3 (best 0.66) |
| 5FE4 | Crystal structure of human pcaf bromodomain in complex with fragment MB364 (fragment 5) | x-ray diffraction | A, B | — | — |
| 5FE5 | Crystal structure of human PCAF bromodomain in complex with fragment MB093 (fragment 7) | x-ray diffraction | A, B | 2QC | — |
| 5FE5 | Crystal structure of human pcaf bromodomain in complex with fragment MB093 (fragment 7) | x-ray diffraction | A, B | — | — |
| 5FE6 | Crystal structure of human PCAF bromodomain in complex with fragment ZB1916 (fragment 10) | x-ray diffraction | A, B | 5WZ | 3 (best 0.68) |
| 5FE6 | Crystal structure of human pcaf bromodomain in complex with fragment ZB1916 (fragment 10) | x-ray diffraction | A, B | — | — |
| 5FE7 | Crystal structure of human PCAF bromodomain in complex with fragment ZB2216 (fragment 11) | x-ray diffraction | A, B | 5WU | — |
| 5FE7 | Crystal structure of human pcaf bromodomain in complex with fragment ZB2216 (fragment 11) | x-ray diffraction | A, B | — | — |
| 5FE8 | Crystal structure of human PCAF bromodomain in complex with compound SL1126 (compound 12) | x-ray diffraction | A, B | 5WT | 3 (best 0.68) |
| 5FE8 | Crystal structure of human pcaf bromodomain in complex with compound SL1126 (compound 12) | x-ray diffraction | A, B | — | — |
| 5FE9 | Crystal structure of human PCAF bromodomain in complex with compound SL1122 (compound 13) | x-ray diffraction | A, B | 5WS | — |
| 5FE9 | Crystal structure of human pcaf bromodomain in complex with compound SL1122 (compound 13) | x-ray diffraction | A, B | — | — |
| 5LVQ | Crystal structure of human PCAF bromodomain in complex with compound-D (CPD-D)… | x-ray diffraction | A, B | 2LX | 3 (best 0.66) |
| 5LVQ | Crystal structure of human pcaf bromodomain in complex with compound-D (cpd-D)… | x-ray diffraction | A, B | 2LX | — |
| 5LVR | Crystal structure of human PCAF bromodomain in complex with compound-E (CPD-E) | x-ray diffraction | A, B | 78Y | 3 (best 0.67) |
| 5LVR | Crystal structure of human pcaf bromodomain in complex with compound-E (cpd-E) | x-ray diffraction | A, B | 78Y | — |
| 5MKX | 1.68A STRUCTURE PCAF BROMODOMAIN WITH 4-chloro-2-methyl-5-(methylamino)pyridazin-3(2H)-one | x-ray diffraction | A, B | 82I, SO4 | 3 (best 0.65) |
| 5MKX | 1.68A structure pcaf bromodomain with 4-chloro-2-methyl-5- (METHYLAMINO)PYRIDAZIN-3(2H)-one | x-ray diffraction | A, B | 82I, SO4 | — |
| 6J3O | Crystal structure of the human PCAF bromodomain in complex with compound 12 | x-ray diffraction | A, B | B4L | 4 (best 0.65) |
| 6J3O | Crystal structure of the human pcaf bromodomain in complex with compound 12 | x-ray diffraction | A, B | B4L | — |
| Q92831 | AlphaFold monomer V2.0 prediction for histone acetyltransferase KAT2B (Q92831) | predicted | A | — | 9 (best 0.71) |
Ligands
- 2LX · N-methyl-2-(tetrahydro-2H-pyran-4-yloxy)benzamide · in 2 records
- 78Y · 5-methyl-2-phenyl-1,2,3-triazole-4-carboxamide · in 2 records
- 82I · 4-chloranyl-2-methyl-5-(methylamino)pyridazin-3-one · in 2 records
- B4L · 3-methyl-2-[[(3~{R})-1-methylpiperidin-3-yl]amino]-5~{H}-pyrrolo[3,2-d]pyrimidin-4-one · in 2 records
- SO4 · Sulfate ion · in 2 records
- 12Q · 1-methylquinolin-2(1H)-one · in 1 record
- 2QC · 1-[4-(1,2,3-thiadiazol-4-yl)phenyl]methanamine · in 1 record
- 5WS · ~{N}-(1,4-dimethyl-2-oxidanylidene-quinolin-7-yl)methanesulfonamide · in 1 record
- 5WT · ~{N}-(1,4-dimethyl-2-oxidanylidene-quinolin-7-yl)ethanamide · in 1 record
- 5WU · 1-(2-hydroxyethyl)-3-methyl-6,7-dihydro-5~{H}-indazol-4-one · in 1 record
- 5WV · 2-methyl-3~{H}-isoindol-1-one · in 1 record
- 5WX · 4-methoxy-1,2-benzoxazol-3-amine · in 1 record
- 5WY · 2,3-dihydro-1,4-benzodioxine-5-carboxamide · in 1 record
- 5WZ · (4-azanylpiperidin-1-yl)-cyclopropyl-methanone · in 1 record
- 5X0 · ~{N}-methyl-2-(oxan-4-yloxy)-5-(2-oxidanylidene-2-phenylazanyl-ethoxy)benzamide · in 1 record
- ALY · N(6)-acetyllysine · in 1 record
Experiment against prediction
- 4NSQ chain A against the predicted model Q92831: TM-score 0.99, RMSD 0.61 Å
- 4NSQ chain A against the predicted model Q92831: TM-score 0.99, RMSD 0.61 Å
- 5FE8 chain B against the predicted model Q92831: TM-score 0.99, RMSD 0.47 Å
- 5FDZ chain B against the predicted model Q92831: TM-score 0.99, RMSD 0.47 Å
- 5FDZ chain B against the predicted model Q92831: TM-score 0.99, RMSD 0.47 Å
- 6J3O chain B against the predicted model Q92831: TM-score 0.98, RMSD 0.54 Å
- 6J3O chain B against the predicted model Q92831: TM-score 0.98, RMSD 0.54 Å
- 5FDZ chain A against the predicted model Q92831: TM-score 0.98, RMSD 0.59 Å
- 5FDZ chain A against the predicted model Q92831: TM-score 0.98, RMSD 0.59 Å
- 1CM0 chain B against the predicted model Q92831: TM-score 0.98, RMSD 0.87 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.